Get the Stockscreener App
1.74
0.58%
0.01
Why is Gain Therapeutics Inc (GANX) Stock down?
We've noticed a 8.40% decline in Gain Therapeutics Inc (GANX) stock during the 2024-11-18 trading session. While this could be attributed to normal volatility or various internal and external factors, please be aware that we are actively monitoring the situation, and we'll provide timely updates as soon as possible!
21 Nov, 2023:
Gain Therapeutics Inc Stock (GANX) dropped by 23.90% from $2.72 to $2.07 in the trading on Tuesday November 21, 2023. The reason why GANX stock down today is due to the announcement of public offering. Gain Therapeutics has announced pricing of $9.4 million public offering of 2,213,044 shares at $2.005/share and accompanying warrants. In connection with the offering, Gain has granted the underwriters a 30-day option to purchase up to an additional 15% of shares of common stock and/or warrants
1.35%
0.87%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):